A review of the role of benzene metabolites and mechanisms in malignant transformation: Summative evidence for a lack of research in nonmyelogenous cancer types

International Journal of Hygiene and Environmental Health

Volumn 212, Issue 1, 2009, Pages 1-10

  Atkinson, Timothy J ^a  

^a NONE   (United Kingdom)

Author keywords

Benzene; Biotransformation; Cancer; Catechol; Hydroquinone; Mechanisms; Metabolites; Myelogenous; Phenol

Indexed keywords

BENZENE; CARCINOGEN; HEMOLYTIC AGENT;

ARTICLE; CELL TRANSFORMATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; OCCUPATIONAL EXPOSURE;

BENZENE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; HEMOLYTIC AGENTS; HUMANS; NEOPLASMS; OCCUPATIONAL EXPOSURE;

EID: 57449119192     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2007.09.013     Document Type: Article

References (69)

1. Anderson D., Yu T.W., and Schmezer P. An investigation of the DNA-damaging ability of benzene and its metabolites in human lymphocytes, using the comet assay. Environ. Mol. Mutagen. 26 (1995) 305-314
2. Andreoli C., Leopardi P., and Crebelli R. Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites. Mutat. Res. 377 (1997) 95-104
3. Aoyama K. Effects of benzene on lymphocyte subpopulations and immune responses in mice. Toxicol. Appl. Pharmacol. 85 1 (1986) 92-101
4. Barale R., Marrazzini A., Betti C., Vangelisti V., Loprieno N., and Barrai I. Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutat. Res. 244 (1990) 15-20
5. Boersma G.M., Balvers W.G., Boeren S., and Vervoort J. Rietjens IMCH: NADPH-cytochrome reductase catalyzed redox cycling of 1,4-benzoquinone; hampered at physiological conditions, initiated at increased pH values. Biochem. Pharmacol. 47 (1994) 1955-1994
6. Brautbar N., Wu M.P., Gabel E., and Regev L. Occupational kidney cancer: exposure to industrial solvents. Ann. NY Acad. Sci. 1076 (2006) 753-764
7. Chakravarti D., Zahid M., Backora M., et al. Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells. Leuk. Lymphoma. 47 12 (2006) 2635-2644
8. Chanvaivit S., Navasumrit P., Hunsonti P., Autrup H., and Ruchirawat M. Exposure assessment of benzene in Thai workers, DNA-repair capacity and influence of genetic polymorphisms. Mutat. Res. 626 1-2 (2007) 79-87
9. Chen H., and Eastmond D.A. Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects. Carcinogenesis 16 (1995) 2301-2307
10. Corti M., and Snyder C.A. Influences of gender, development, pregnancy and ethanol consumption on the hematotoxicity of inhaled 10 ppm benzene. Arch. Toxicol. 70 3-4 (1996) 209-217
11. Corti M., and Snyder C.A. Gender and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicol. Sci. 41 1 (1998) 42-48
12. Drummond J.C., and Finar I.L. Muconic acid as a metabolic product of benzene. Biochemistry 32 (1938) 79-84
13. Eastmond D.A., Smith M.T., Ruzo L.O., and Ross D. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase. Mol. Pharmacol. 30 (1986) 674-679
14. Fabiani R., De Bartolomeo A., Rosignoli P., Scamosci M., Lepore L., and Morozzi G. Influence of culture conditions on the DNA-damaging effect of benzene and its metabolites in human peripheral blood mononuclear cells. Environ. Mol. Mutagen. 37 (2001) 1-6
15. Farris G.M., Robinson S.N., Gaido K.W., Wong B.A., Wong V.A., et al. Benzene-induced hematoxicity and bone marrow compensation in B6C3F1 mice. Fundam. Appl. Toxic. 36 2 (1997) 119-129
16. Forni A. Chromosome changes and benzene exposure. A review. Rev. Environ. Health 11 (1979) 5-17
17. Glass D.C., Gray C.N., Jolley D.J., Gibbons C., and Sim M.R. The health watch case-control study of leukemia and benzene: the story so far. Ann. NY Acad. Sci. 1076 (2006) 80-89
18. Goldstein B.C., Snyder C.A., Laskin S., Bromberg I., Albert R.E., and Nelson N. Myclogenous leukemia in rodents inhaling benzene. Toxicol. Lett. 19 (1982) 169-173
19. 14C-labelled benzene metabolites in the rat. Chem. Biol. Interact. 74 (1981) 55-62
20. Gut I., Nedelcheva V., Soucek P., Stopka P., and Tichavska B. Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ. Health Perspect. 104 Suppl. 6 (1996) 1211-1218
21. Heddle J.A., Hite M., Kirkhart B., Mavoumin K., MacGregor J.T., Newell G.W., and Salamone M.F. The induction of micronuclei as a measure of genotoxicity. A report of the US Environmental Protection Agency Gene-Tox Program. Mutat. Res. 123 (1983) 61-118
22. Henschler R., Glatt H.R., and Heyworth C.M. Hydroquinone stimulates granulocyte-macrophage progenitor cells in vitro and vivo. Environ. Health Perspect. 104 Suppl. 6 (1996) 1271-1274
23. Hirabayashi Y., Yoon B.I., Li G.X., Kanno J., and Inoue T. Mechanism of benzene-induced hematotoxicity and leukemogenicity: current review with implication of microarray analyses. Toxicol. Pathol. 32 Suppl. 2 (2004) 12-16
24. Huff J. Animal and human carcinogens. Environ. Health Perspect. 107 (1999) A341-A342
25. Huff J. Benzene-induced cancers: abridged history and occupational health impact. Int. J. Occup. Environ. Health 13 (2007) 213-221
26. Huff J., Melnick R.L., Solleveld H.A., Haseman J.K., Powers M., and Miller R.A. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 227 4686 (1985) 548-549
27. Hutt A.M., and Kalf G.F. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ. Health Perspect. 104 Suppl. 6 (1996) 1265-1269
28. Infante P.F. Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. Ann. NY Acad. Sci. 1076 (2006) 90-109
29. Irons R.D., and Neptun D.A. Effects of principle hydroxyl-metabolites of benzene on microtubule polymerization. Arch. Toxicol. 45 (1980) 297-305
30. Irons R., Dent J., Baker T., and Rickart D. Benzene is metabolized and covalently bound in bone marrow in situ. Chem. Biol. 30 (1980) 241-245
31. Kline S.A., Roberston J.F., Grotz V.L., Goldstein B.D., and Witz G. Identification of 6-hydroxy-trans, trans-2,4-hexadienoic acid, a novel ring-opened urinary metabolite of benzene. Environ. Health. Perspect. 101 (1993) 310-312
32. Kolachana P., Subrahmanyam V.V., Meyer K.B., Zhang L., and Smith M.T. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 53 (1993) 1023-1026
33. Levay G., Pongracz K., and Bodell W.J. Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabelling. Carcinogenesis 12 7 (1991) 1181-1186
34. Leva G., Ross D., and Bodell W.J. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis 14 (1993) 2329-2334
35. Low L.K., Reddy M.V., Blackburn G.R., and Mackerer C.R. Final Report: Benzene Mechanistic Research Project (1991), Environmental and Health Laboratory Mobil Oil Corporation, Princeton, NJ
36. Lunte S.M., and Kissinger P.T. Detection and identification of sulfhydryl conjugates of p-benzoquinone in microsomal incubations of benzene and phenol. Chem. Biol. Interact. 47 (1983) 195-212
37. Marrazzini L., Chelotti I., Barrai N., Loprieno N., and Barale R. In vivo genotoxic interactions among three phenolic benzene metabolites. Mutat. Res. (1994) 29-34
38. Mattia C.J., Adams Jr. J.D., and Bondy S.C. Free radical induction in the brain and liver by products of toluene catabolism. Biochem. Pharmacol. 6:46 1 (1993) 103-110
39. Mehlman M.A. Causal relationship between non-Hodgkin's lymphoma and exposure to benzene and benzene-containing solvents. Ann. NY Acad. Sci. 1076 (2006) 120-128
40. Melnick R.L., Huff J., Chou B.J., and Miller R.A. Carcinogenicity of 1,3-butadiene in C57BL/6_C3H F1 mice at low exposure concentrations. Cancer Res. 50 (1990) 6592-6599
41. Mueller G., Koelbl M., Hegar M., and Norpoth K. Urinary S-phenyl mercapturic acid and phenylguanine as indicators of benzene exposure. In: Ho M.H., and Dillion H.K. (Eds). Biological Monitoring of Exposure to Chemicals, Organic Compounds (1987), Wiley, New York 91-98
42. Nerland D.E., and Pierce W.M. Identification of N-acetyl-S-(2,5-dihydroxyphenyl)-l-cysteine as a urinary metabolite of benzene, phenol and hydroquinone. Drug. Metab. Dispos. 18 6 (1990) 958-961
43. Norporth K., Stucker W., Krewet E., and Mueller G. Biomonitoring of benzene exposure by trace analysis of phenylguanine. Int. Arch. Occup. Environ. Health 60 (1988) 163-168
44. Parke D.V., and Williams R.T. Studies in detoxication. 54. The metabolism of benzene. (a) The formation of phenylglucuronide and phenylsulphuric acid from [14C] benzene. (b) The metabolism of [14C] phenol. Biochem. J. 55 2 (1953) 337-340
45. Pyatt D. Benzene and hematopoietic malignancies. Clin. Occup. Environ. Med. 4 3 (2004) 529-555
46. Rana S.V., and Verma Y. Biochemical toxicity of benzene. J. Environ. Biol. 26 2 (2005) 157-168
47. Rickert D.E., Baker T.S., Bus J.S., Barrow C.S., and Irons R.D. Benzene disposition in the rat after exposure by inhalation. Toxicol. Appl. Pharmacol. 49 (1979) 417-423
48. Rivedal E., and Witz G. Benzene metabolites block gap junction intercellular communication. Role in hematoxicity and leukaemia?. Chem. Biol. Interact. 153-154 (2005) 257-260
49. Rivedal E., and Witz G. Metabolites of benzene are potent inhibitors of gap-junction intercellular communication. Arch. Toxicol. 79 6 (2005) 303-311
50. Rosenthal G.J., and Snyder C.A. Inhaled benzene reduces aspects of cell-mediated tumor surveillance in mice. Toxic. Appl. Pharmacol. 88 1 (1987) 35-43
51. Rozen M.G., and Snyder C.A. Protracted exposure of C57BL/6 mice to 300 ppm benzene depresses B- and T-lymphocyte numbers and mitogen responses. Evidence for thymic and bone marrow proliferation in response to the exposure. Toxicology 1-2 (1985) 13-26
52. Sabourin P.J., Bechtold W.E., Birnbaum L.S., Lucier G., and Henderson R.F. Differences in the metabolism and disposition of inhaled [3H] benzene by F344/N rats and B6C3F1 mice. Toxic. Appl. Pharmacol. 94 (1988) 128-140
53. Sabourin P.J., Bechtold W.E., and Henderson R.F. A high pressure liquid chromatographic method for the separation and quantitation of water-soluble radiolabeled benzene metabolites. Anal. Biochem. 170 (1988) 316-327
54. Sammett D., Lee E.W., Kocsis J.J., and Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health. 5 (1979) 785-792
55. Shen Y., Shen H.M., Shi C.Y., and Ong C.N. Benzene metabolites enhance reactive oxygen species generation in HL60 human leukemia cells. Hum. Exp. Toxicol. 15 5 (1996) 422-427
56. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health. Perspect. 104 Suppl. 6 (1996) 1219-1225
57. Smith M.T., Jones R.M., and Smith A.H. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 16 3 (2007) 385-391
58. Snyder R., and Hedli C.C. An overview of benzene metabolism; supplement: benzene toxicity, carcinogenesis, and epidemiology. Environ. Health Perspect. 104 Suppl. 6 (1996) 1165-1171
59. Subrahmanyam V.V., Doane-Setzer P., Steinmetz K.L., Ross D., and Smith M.T. Phenol induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology 62 (1990) 107-116
60. Subrahmanyam V.V., Ross D., Eastmond D.A., and Smith M.T. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic. Biol. Med. 11 5 (1991) 495-515
61. Tsutsui T., Hayashi N., Maizumi H., Huff J., and Barrett J.C. Benzene- catechol-, hydroquinone- and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutat. Res. 373 (1997) 113-123
62. 1 Mice (Gavage Studies) 〈http://ntp.niehs.nih.gov/index.cfm?objectid=0707525C-0F07-05BF-A16CAC7B0ECC97B5〉.
63. Valentine J.L., Lee S.S.T., Seaton M.J., Asgharian B., Farris G., et al. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141 (1996) 205-213
64. Vigliani E.C., and Forni. Benzene, chromosome changes and leukemia. J. Occup. Med. 11 (1969) 148-149
65. Wan J., and Winn L.M. The effects of benzene and the metabolites phenol and catechol on c-Myb and Pim-1 signaling in HD3 cells. Toxicol. Appl. Pharmacol. 201 2 (2004) 194-201
66. Wan J., Badham H.J., and Winn L. The role of c-MYB in benzene initiated toxicity. Chem. Biol. Interact. 153-154 (2005) 171-178
67. Ward Jr. J.B., Ammenheuser M.M., Ramanujam V.M., Morris D.L., Whorton Jr. E.B., and Legator M.S. The mutagenic effects of low level sub-acute inhalation exposure to benzene in CD-I mice. Mutat. Res. 268 (1992) 49-57
68. Wong O., and Fu H. Exposure to benzene and non-Hodgkin lymphoma, an epidemiological overview and an ongoing case-control study in Shanghai. Chem. Biol. Interact. 153-154 (2005) 33-41
69. Yin S.N., Hayes R.B., Linet M.S., et al. An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ. Health Perspect. 104 Suppl. 6 (1996) 1339-1341